Tag:
Echo Therapeutics
Latest Headlines
Latest Headlines
Echo's trandsdermal tech gets positive results, TV time
Echo Therapeutics is reporting positive clinical trial results for its transdermal glucose monitor, and its CEO will get a chance to discuss them on national TV.
Echo Therapeutics reports $16.7M loss after Prelude delay
Philadelphia-based Echo Therapeutics took a $16.7 million loss in 2011, a year in which the company had planned to launch its needle-free, transdermal drug delivery platform, the Prelude SkinPrep System.
Echo Therapeutics video shows pain-free skin prep
When last we left Echo Therapeutics in February , the Franklin, MA-based company was speeding up the launch of its Prelude SkinPrep System for transdermal drug delivery after receiving word from the
Echo Therapeutics: Prelude delivery device launch on track
Franklin, MA-based Echo Therapeutics is speeding up the launch of its non-invasive drug delivery system and announced plans to list on a national exchange. The company, along with its partners
